Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Gen-Probe Incorporated (Gen-Probe) has appointed Carl Hull as chief executive officer (CEO) of the company. Carl Hull succeeded long-time leader, Henry Nordhoff, as CEO of the company. Carl Hull, formerly Gen-Probe's president and chief operating officer, also has joined the company's board of directors. As first announced on March 23, 2009, Henry Nordhoff retired as CEO on May 17, 2009.
Subscribe to our email newsletter
Henry Nordhoff, who had served as its CEO since 1994, is now non-executive chairman following his re-election to the board at the company’s annual meeting of stockholders last week.
Hank Nordhoff has built a successful and dynamic company in his 15 years at the helm of Gen-Probe, and helped safeguard the health of literally millions of people worldwide through our blood screening and infectious disease testing products, Hull said. I am honored by the opportunity to succeed him, and look forward to his continued guidance as chairman of our board.
Gen-Probe is a developer, manufacturer and marketer of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood.